Skip to Main Content

Author Details

Ernst Lengyel
University of Chicago
1993
168
64
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36114807Ovarian Masses: The Value of Acoustic Shadowing on Ultrasound Examination.J Ultrasound Med2023
38014221Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression.medRxiv2023
37653041Adipocytes reprogram cancer cell metabolism by diverting glucose towards glycerol-3-phosphate thereby promoting metastasis.Nat Metab2023
37345662Normal saline remodels the omentum and stimulates its receptivity for transcoelomic metastasis.JCI Insight2023
37311411Decoding evolutionary trajectories of ovarian cancer metastasis.Cancer Cell2023
36973758The glycoprotein CD147 defines miRNA-enriched extracellular vesicles that derive from cancer cells.J Extracell Vesicles2023
37440228Diagnostic Performance of Ultrasonography-Based Risk Models in Differentiating Between Benign and Malignant Ovarian Tumors in a US Cohort.JAMA Netw Open2023
37128849Understanding Long-Term Survival of Patients with Ovarian Cancer-The Tumor Microenvironment Comes to the Forefront.Cancer Res2023
36795484Cancer-associated mesothelial cell-derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis.JCI Insight2023
34651237Resilience: a mediator of the negative effects of pandemic-related stress on women's mental health in the USA.Arch Womens Ment Health2022
35590073Deep Visual Proteomics defines single-cell identity and heterogeneity.Nat Biotechnol2022
35519002High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas.Gynecol Oncol Rep2022
36543131A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing.Cell Rep2022
35941408The adipocyte microenvironment and cancer.Cancer Metastasis Rev2022
36139624Molecular Characterizations of Gynecologic Carcinosarcomas: A Focus on the Immune Microenvironment.Cancers (Basel)2022
35201895Resilience in the Face of Pandemic: The Impact of COVID-19 on the Psychologic Morbidity and Health-Related Quality of Life Among Women With Ovarian Cancer.JCO Oncol Pract2022
34737212Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer.Cancer Res2022
32820089Healthy food for trainees: a call to action.Postgrad Med J2021
33818123Change in Health-Related Socioeconomic Risk Factors and Mental Health During the Early Phase of the COVID-19 Pandemic: A National Survey of U.S. Women.J Womens Health (Larchmt)2021
34439084The Natural Product β-Escin Targets Cancer and Stromal Cells of the Tumor Microenvironment to Inhibit Ovarian Cancer Metastasis.Cancers (Basel)2021
34452747Germline mutations in Black patients with ovarian, fallopian tube and primary peritoneal carcinomas.Gynecol Oncol2021
34224372The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer.Cancer Res2021
33964209Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis.Cell2021
34201616The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment.Cancers (Basel)2021
33278287Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment.Obstet Gynecol2021
30807370Interpretation of Mismatch Repair Protein Immunohistochemistry in Endometrial Carcinoma Should Consider Both Lynch Syndrome Screening and Immunotherapy Susceptibility: An Illustrative Case Report.Int J Gynecol Pathol2020
32054768Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.Cancer Res2020
33088423Deconstructing tumor heterogeneity: the stromal perspective.Oncotarget2020
33215053Complete Response in a Patient With Chemorefractory <i>EGFR</i>-Amplified, PD-L1-Positive Metastatic Gastric Cancer Treated By Dual Anti-EGFR and Anti-PD-1 Monoclonal Antibody Therapy.JCO Precis Oncol2020
32840618Are We Ready for Hyperthermic Intraperitoneal Chemotherapy in the Upfront Treatment of Ovarian Cancer?JAMA Netw Open2020
31562255Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis.Mol Cancer Ther2020
30471899The road to long-term survival: Surgical approach and longitudinal treatments of long-term survivors of advanced-stage serous ovarian cancer.Gynecol Oncol2019
31646189Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake.Commun Biol2019
31870409RADAR: differential analysis of MeRIP-seq data with a random effect model.Genome Biol2019
31851935Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk.Cell Rep2019
30174305Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis.Cell Metab2019
31311654New Roles for Glycogen in Tumor Progression.Trends Cancer2019
31591248Ultrasensitive, multiplexed chemoproteomic profiling with soluble activity-dependent proximity ligation.Proc Natl Acad Sci U S A2019
30835824Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference.Cancer2019
30914657Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6.Sci Rep2019
30797592Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.Gynecol Oncol2019
30655321SPHK1 Is a Novel Target of Metformin in Ovarian Cancer.Mol Cancer Res2019
30396040A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns.Biomaterials2019
30567719Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum.J Exp Med2019
29128106Who are the long-term survivors of high grade serous ovarian cancer?Gynecol Oncol2018
30241606Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer.Cell2018
30154548m<sup>6</sup>A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer.Nat Cell Biol2018
30064659The Tumor Microenvironment Takes Center Stage in Ovarian Cancer Metastasis.Trends Cancer2018
29720506Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor-Engineered T Cells for Ovarian Cancer.Clin Cancer Res2018
29709261Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors.Trends Cancer2018
  • 1 - 50 of 168

Recommended Authors

Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 6
Boris Winterhoff
University of Minnesota
Career Start Year 2008
Number of shared co-authors 25
Ruby Yun-Ju Huang
National Taiwan University College of Medicine
Career Start Year 2008
Number of shared co-authors 21
Yingmei Wang
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 1
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 21
Brigitte L Th??riault
Ontario Institute for Cancer Research, University Avenue
Career Start Year 2004
Number of shared co-authors 0
Sven Mahner
University Hospital
Career Start Year 2002
Number of shared co-authors 23
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 3
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 8
Aparna A Kamat
Houston Methodist Hospital
Career Start Year 2000
Number of shared co-authors 2
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 1
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 3
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 7
Jacqueline F Donoghue
University of Melbourne
Career Start Year 1995
Number of shared co-authors 0
Yong-Man Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1994
Number of shared co-authors 0
Denise C Connolly
Fox Chase Cancer Center
Career Start Year 1993
Number of shared co-authors 3
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 4
George L Maxwell
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1992
Number of shared co-authors 25
Rosalind Glasspool
University of Glasgow
Career Start Year 1992
Number of shared co-authors 26
Sandra Orsulic
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 1992
Number of shared co-authors 30
Rosemarie Schmandt
The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 4
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 1
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 6
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Career Start Year 1988
Number of shared co-authors 1
Francesco Caiazza
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1987
Number of shared co-authors 0
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 4
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 4
Adrian L Harris
University of Oxford
Career Start Year 1981
Number of shared co-authors 6
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 1

Collaborators

Mark A Eckert
Medical University of South Carolina
Co-authored papers 15
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 6
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Co-authored papers 5
Ronny Drapkin
University of Pennsylvania School of Medicine
Co-authored papers 5
Euan A Stronach
Imperial College London
Co-authored papers 4
Min Shen
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 4
Fabian Coscia
Max-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC)
Co-authored papers 4
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 3
Matthias Mann
Max-Planck Institute of Biochemistry
Co-authored papers 3
Joshy George
Peter MacCallum Cancer Centre
Co-authored papers 3
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 3
Anil K Sood
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Andreas Mund
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers 3
Dariush Etemadmoghadam
Peter MacCallum Cancer Centre
Co-authored papers 3
Oliver Fiehn
University of California davis
Co-authored papers 3
Jason W Locasale
Duke University
Co-authored papers 3
Douglas A Levine
Perlmutter Cancer Center
Co-authored papers 3
Zhuyin Li
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 2
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Chuan He
Institute of Hematology, West China Hospital of Sichuan University
Co-authored papers 2
Katia Nones
QIMR Berghofer Medical Research Institute
Co-authored papers 2
Youjia Hua
Co-authored papers 2
Sean M Grimmond
The University of Melbourne
Co-authored papers 2
Maria A Doyle
Peter MacCallum Cancer Centre
Co-authored papers 2
Nadia Traficante
Peter MacCallum Cancer Centre
Co-authored papers 2
Beatrice S Knudsen
University of Utah
Co-authored papers 2
Yoke-Eng Chiew
Westmead Hospital
Co-authored papers 2
Robert Brown
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 2
Joy Hendley
Peter MacCallum Cancer Centre
Co-authored papers 2
George Au-Yeung
The University of Melbourne
Co-authored papers 2
Release 1.2